Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- WORLD NEWS IN BRIEF
October 1, 2001
- Wholesalers' Gross Profit Rate Drops to Below 9%
October 1, 2001
- RIKEN to Collaborate with 14 Japanese Companies for Pharmacogenomic Research
October 1, 2001
- BUSINESS NEWS IN BRIEF
October 1, 2001
- New Results from Japan Lipid Intervention Trial Presented: Banyu
October 1, 2001
- PMSB Requires Enhanced Safety Measures Regarding Statins
October 1, 2001
- Patients' Wishes Should Be Respected in Endometriosis Treatment: Kissei Forum
October 1, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 1, 2001
- 81% of Insulin-treated Patients Experience Hypoglycemia
October 1, 2001
- Health Minister Briefs PM about Healthcare Reform Proposals
October 1, 2001
- ICIT, SMBG Contribute to Better Treatment of Diabetes: Prof. Iwamoto
October 1, 2001
- ADR Report Handling Policy Should Be in Accordance with Int'l Standards: PMSB
October 1, 2001
- OPMA Reviews Problems Related to Clinical Trials at Clinics
October 1, 2001
- 51% of JPMA Member Firms Have Documented Compliance Programs
September 24, 2001
- Makers Outsource More OTC Drug Marketing Activities
September 24, 2001
- FJPWA Decides to Cooperate in Market Price Survey
September 24, 2001
- OTC NEWS IN BRIEF
September 24, 2001
- Wholesalers' Bargaining Ability to Be Tested in 2002
September 24, 2001
- WORLD NEWS IN BRIEF
September 24, 2001
- BUSINESS NEWS IN BRIEF -1-
September 24, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…